Analyst firms · Oppenheimer · ARVN
Oppenheimer ARVN price target and rating history
Arvinas Inc. (ARVN) · Health Care
Oppenheimer rates Arvinas Inc. (ARVN) Perform with a $80 price target, as of its latest action on Mar 11, 2025. It has published 4 rating actions on ARVN since July 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Perform
- Price target
- $80
- Median target, all firms
- Too few
- Actions on ARVN
- 4
Oppenheimer price target on ARVN
Every Oppenheimer rating on ARVN
- Mar 11, 2025
- Feb 28, 2024
- Jun 26, 2023
- Jul 23, 2021
How other firms rate ARVN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Equal Weight | Aug 4, 2026 | |
| Citigroup | Buy | $15 | Jan 6, 2026 |
Questions about Oppenheimer and ARVN
- What is Oppenheimer's price target for ARVN?
- Oppenheimer's latest stated price target for Arvinas Inc. (ARVN) is $80, from its action on Feb 28, 2024.
- What is Oppenheimer's rating on ARVN?
- Oppenheimer rates ARVN Perform, a neutral rating, as of Mar 11, 2025.
- When did Oppenheimer last change its view on ARVN?
- On Mar 11, 2025, Oppenheimer downgrades to Perform from Outperform.
More ARVN rating histories
All Oppenheimer ratingsARVN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.